TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (“MediPharm”) (TSXV: LABS) is pleased to announce that it has entered into a Cannabis Concentrate Program Agreement (the “Agreement”)...
Emerald Health Therapeutics Announces Amendment from Health Canada for Pure Sunfarms’ Cultivation License, Expanding Cannabis Production Area to Approximately 550,000 Square Feet in One of the Single Largest Cannabis...
OCS Announces New Supply Agreements With Additional Licensed Producers and Accessories Suppliers September 5, 2018 — Further to the initial supply announcement on August 20, the Ontario Cannabis Store...
This is a copy of the May 6th edition of our weekly Newsletter, which we have been publishing since October, 2015. Friends, With so much interest in the the...
Emerald Health Therapeutics Acquires Cannabis Licensed Producer in Québec New Emerald operation, one of only six licensed producers in Québec, adds indoor growing capacity of approximately 10,000 kg per...
Village Farms International and Emerald Health Therapeutics Announce Cannabis Cultivation License for 1.1 Million ft2 Delta 3 Greenhouse Operation – Unmatched Experience and Expertise and Optimized Facility Design Will...
In 2017, the first two exchange-traded funds (ETF) focused on publicly-traded cannabis stocks emerged, including Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (TSX: HMMJ.U) (OTC: HMLSF) in April...
Emerald Health Announces $15 Million Prospectus Sale; Concurrent Secondary Sale VICTORIA, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald” or the...
Cannabis stocks surged 51.8% in December after a 58.3% gain in November. For the full year, the Cannabis Stock Index rose from 74.10 to 142.10, an increase of 91.8%: Like...
Despite a flood of supply this month, Canadian LP stock performance stands out so far in October as investors have retreated somewhat from the overall sector. The Cannabis Stock...
Emerald Health Therapeutics Appoints Pharmaceutical Marketing and Biotech Executive Chris Wagner as CEO VICTORIA, British Columbia, Oct. 02, 2017 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (“EHT”) (TSXV: EMH)...
Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), the world’s first and still only cannabis ETF, has adjusted its portfolio this month as its benchmark, the North...
Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals VICTORIA, British Columbia, Sept. 19, 2017 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (EHT) (TSXV: EMH) (OCTQX:...
After a big 2nd half of 2016 and some strength in early 2017, Canadian LPs were under heavy pressure from April through June following a glut of supply (new...
